Veeva AI

Sales & Marketing

On Wednesday 5th November, Veeva Commercial Summit kicked off with a bang in Madrid, unveiling upcoming Veeva AI rollouts.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.